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ASSESSING THE ASSOCIATION BETWEEN TRENDS IN
A BIOMARKER AND RISK OF EVENT WITH
AN APPLICATION IN PEDIATRIC HIV/AIDS
By Elizabeth R. Brown1
University of Washington
We present a new joint longitudinal and survival model aimed
at estimating the association between the risk of an event and the
change in and history of a biomarker that is repeatedly measured over
time. We use cubic B-splines models for the longitudinal component
that lend themselves to straight-forward formulations of the slope
and integral of the trajectory of the biomarker. The model is applied
to data collected in a long term follow-up study of HIV infected in-
fants in Uganda. Estimation is carried out using MCMC methods.
We also explore using the deviance information criteria, the condi-
tional predictive ordinate and ROC curves for model selection and
evaluation.
1. Introduction. In longitudinal studies it is common to monitor one or
more biomarkers repeatedly over time while following participants until the
occurrence of an event. Researchers are often interested in examining both
the repeated measures and the time to event to gain an understanding of
the underlying disease process. Additionally, the risk of an event may not
depend solely on the level of the biomarker but also on the rate at which that
biomarker is changing or its past average level. For example, two patients
may present with the same biomarker value, but one patient’s biomarker
trajectory may be increasing while the other’s is remaining constant. Their
prognosis may appear to be be the same if only the current value is accounted
for, but in fact the patient with the increasing biomarker may be at higher
risk. In this paper we present a model to estimate the association between
the risk of an event and the current value, as well as the rate of change or
history of a longitudinally sampled biomarker. We illustrate the approach
from a sub-study of HIVNET 012 [Guay et al. (1999); Jackson et al. (2003)]
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of HIV disease progression in Ugandan children who acquired HIV vertically,
either in utero, during delivery or via breastmilk. In this sub-study children
who tested positive before 18 months of age were followed until five years
of age with blood samples drawn every 6 months. From these samples, the
lab determined viral load, total lymphocyte count (TLC), CD4 percent and
other related biomarkers. One aim was to determine the predictive value
of these measures for time until death. In this manuscript we explore the
association between change in and history of these markers and the risk of
death. Overall, 128 children were followed after their first positive HIV test
with lab measurements taken at regular intervals. Of these 128 infants, 70
died during follow-up.
In estimating the association between trends in a biomarker or set of
biomarkers and the risk of an event, we face two important and distinct
challenges. The first is selecting the correct model when the biomarker is
collected in discrete time with error. The second is to determine how to
obtain different summaries of the biomarker(s) and include them in the
time to event model.
The first issue and its resolution through joint modeling of the time to
event and longitudinal marker has been studied extensively as summarized
by Tsiatis and Davidian (2004) when dealing with the current level of a
biomarker and the risk of an event. In summary, survival analyses with
time-dependent covariates can be biased if we simply include the raw mea-
surements in the survival analysis [Prentice (1982)]. Joint longitudinal and
survival models resolve this issue by modeling the biomarker process over
time and including subject-specific parameters from the longitudinal model
as covariates in the survival model. These same issues exist when trying to
include other summaries of the biomarker process in the survival model, and
may, in fact, be exacerbated.
Wulfsohn and Tsiatis (1997) and Faucett and Thomas (1996) introduced
likelihood-based methods for analyzing a longitudinal marker and its asso-
ciation with the time to event simultaneously. This class of models is not
restricted to linking the time-varying value of the longitudinal marker to
the time-varying hazard through a regression on the current value of longi-
tudinal model. They may instead include other information from the longi-
tudinal trajectories summarized by the longitudinal model. Several authors
have proposed models that group the trajectories into latent classes, then
link the hazard and the longitudinal model by the latent class [Lin et al.
(2002); Proust-Lima, Letenneur and Jacqmin-Gadda (2007); Han, Slate and
Pena (2007); Proust-Lima et al. (2009)]. These models can help characterize
longitudinal trajectories that may indicate a higher risk for event. In these
models the latent class for the trajectory of the biomarker is defined based
on the entire follow-up for the biomarker, which may have the drawback of
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using information about the biomarker from the future to estimate risk in
the present.
Other descriptors from the longitudinal model have also been used to
link the trajectory of the biomarker to risk of event. Yu, Taylor and San-
dler (2008) developed individual risk prediction models for prostate cancer
recurrence based on PSA trajectories. PSA was modeled using a nonlin-
ear exponential decay and exponential growth model. The current value as
well as slope (first derivative) of the PSA trajectory were included as time-
varying covariates in the hazard model. Ye, Lin and Taylor (2008) presented
a two-stage regression calibration approach for modeling longitudinal and
time-to-event data. Their longitudinal model included smoothing splines at
the population level with individual deviations from the smoothing spline
allowed through a mean 0 integrated Wiener process and subject-specific
slopes and intercepts. Both the current value and slope of the subject-specific
trajectories were included as covariates in the hazard model.
In this manuscript we extend the work of Brown, Ibrahim and DeGruttola
(2005) who used cubic B-splines to model the impact of multiple biomarkers
on time to event to include the slope and integral of the cubic B-spline mod-
els as time-varying covariates in the hazard model. They showed that cubic
B-splines provided flexibility in the biomarker model that simple parametric
models could not. Because cubic B-spline trajectory models and their slopes
and integrals are linear functions of the parameters that do not increase
exponentially with time, they avoid computational instability. Additionally,
because the basis functions of the cubic B-splines weight more heavily on
local (in time) information for estimating the value of the trajectory, esti-
mates of the slope early in follow-up do not rely heavily on values of the
biomarker observed late in follow-up.
The paper proceeds as follows. In the next section we review cubic B-spline
models for longitudinal data and outline the model associating change and
cumulative exposure with time to event. Next, we discuss estimation and
model selection procedures. We then show an example from HIVNET 012.
We conclude with a discussion.
2. The joint longitudinal and survival model. In this section we describe
a joint longitudinal and survival model to estimate the association between
the rate of change in a biomarker or cumulative history of a biomarker and
the risk of an event. We begin with a description of the notation and a
review of the longitudinal cubic B-spline model, including expressions for
the first derivatives and integrals. We then introduce the model linking the
biomarker and its rate of change or cumulative history to the risk of event.
2.1. The longitudinal model. Let yijl denote the ith, i = 1, . . . ,N, sub-
ject’s jth, j = 1, . . . ,mi, observation of the lth, l = 1, . . . ,L, biomarker at
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time tij < T , where T denotes the end of follow-up. We define an observa-
tion at time tij to be a function of the true underlying trajectory ψ(tij) plus
error,
yijl = ψl(tij) + eijl,
where the errors are independent and normally distributed such that (eij1, . . . ,
eijL)
′ ∼Nl(0,Σ), whereNl(a, b) is the l-dimensional multivariate normal dis-
tribution with mean vector a and covariance matrix b. Brown, Ibrahim and
DeGruttola (2005) modeled the true, but unobserved, trajectory using cubic
B-splines such that
ψl(t) =
q∑
k=1
βilkBk(t),(2.1)
where {Bk(·)} is a q¯-dimensional basis for spline functions on [0, T ] with
a fixed knot sequence, u= (u1, . . . , uq+4) and βil = (βil1, . . . , βilq)
′ is a vec-
tor of subject-specific parameters of length q that determine the shape of
the ith subject’s trajectory. We assume a hierarchical model where βil ∼
Nl(b0l +X
′
iαl, V0l). In this model the effect of the covariates is modeled at
the population level where αl is a vector of parameters of length p linking
the vector of baseline covariates Xi to the longitudinal outcome and b0 is the
vector of length q of the mean of the coefficients for the kth basis function
when Xi1, . . . ,Xip = 0. Brown, Ibrahim and DeGruttola (2005) showed the
merits (better mixing in the Gibbs sampler and more flexible effect of the
covariate on the longitudinal outcome) of modeling the effect of covariates
on the longitudinal model in this level of the hierarchy. As a further exten-
sion, we allow for a covariance structure for the spline coefficients where V0l
is the q × q covariance matrix of the coefficients of the basis functions.
An individual’s contribution to the likelihood of the longitudinal marker
can be expressed as
p(Yi|Σ, βi)∝
1
|Σ|mi
exp
{
−
1
2
mi∑
j=1
(Yij − ψ(tij))
′Σ−1(Yij − ψ(tij))
}
,(2.2)
where Yij = (yij1, . . . , yijL)
′ and ψ(tij) = (ψ1(tij), . . . , ψL(tij))
′.
2.2. The joint model. We next review the form of the joint model when
we are only interested in modeling the relationship between the level of the
marker at time t and the hazard at time t. We then show how the spline
model of the trajectory can be used to describe the rate of change in and
history of the biomarker. Next, we incorporate these functionals into the
hazard, thus extending the joint model to estimate the impact of the rate
of change and history on the risk of an event.
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The usual joint longitudinal and survival model assumes proportional
hazards, and the effect of the trajectories of the biomarkers on the hazard
is modeled as
λ(t) = λ0(t) exp(γ
′ψ(t) +Z ′iζ),(2.3)
where λ0(t) is the baseline hazard at time t, γ is a parameter vector of length
L linking the trajectory vector at time t to the hazard at time t, and ζ is a
vector of parameters of length pz linking the vector of baseline covariates Zi
to the hazard. Taking a likelihood approach requires some specification of
the baseline hazard. Here, we specify a piecewise constant hazard allowing
for approximately 8–10 events in each interval, where
λ0(t) = λj, wj ≤ t < wj+1, j = 1, . . . , J,
where the wj ’s are the jump points with w1 = 0 and wJ+1 =∞.
Then the cumulative hazard,∫ si
0
λ(u)eγ
′ψ(u)+z′
i
ζ du,
can be rewritten as
ez
′
i
ζ
J∑
j=1
Hij(β, γ,λ),
where
Hij(β, γ,λ) = I{si ≥ uj−1}λj
∫ min(uj ,si)
uj−1
eγ
′ψ(u)+z′
i
ζ du(2.4)
and I{si ≥ uj−1} is an indicator function which equals 1 if the event time
occurs in or later than the jth interval and 0 otherwise. The integral in (2.4)
does not have an analytical solution for the trajectory defined by cubic B-
splines. Instead, for computational ease and speed, we use Gaussian quadra-
ture to approximate it.
Extending the model to include the relationship between another function
or functions of the time-varying covariates and the hazard requires adding
another term to the model. If we are interested in the relationship between
rate of change of the biomarker and the hazard, we include the first deriva-
tive of ψ(t). If we are interested in the relationship between the cumulative
history of the biomarker and the hazard, we include the integral of ψ(t).
For clarity, we drop the subscripts for definition of the first derivative and
integral. The first derivative of the trajectory function as shown by de Boor
[(2001), page 116] can be expressed as
ψ′(t) =B(2)∗(t)′β,(2.5)
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where B(2)∗(t) is a vector of length q with the jth element equal to
B
(2)
j
(t)
uj+3−uj
−
B
(2)
j+1(t)
uj+4−uj+1
, and B(2)(t) is the quadratic B-spline based on the same sequence
of knots as the original B-spline in (2.1) with the first and last knot removed.
Equation (2.5) is written as a linear function of the elements of βi; however,
it is a quadratic B-spline and still retains many of the desirable properties
of B-splines mentioned earlier.
The general idea for calculating the integral of the cubic B-spline was laid
out by de Boor [(2001), page 128]. We derived the integral of the trajectory
up to time t to be ∫ t
0
ψ(v)dv = ψ(−1)(t) =B∗(4)(t)′β,(2.6)
whereB∗(4)(t) is a vector of length q with jth element equal to
∑q+1
k=j+1B
(4)
k (t)×
(
uj+4−uj
4 ), and {B
(4)
k (·)} is the vector of q + 1-dimensional basis of a quar-
tic B-spline based on the knot vector u augmented by two arbitrary knots,
u0 <u1 and uq+5 >uq+4.
To link the rate of change and history of the trajectories to the hazard,
we use the following regression model:
λ(t) = λ0(t) exp{γ
′ψ(t) + γ′sψ
′(t) + γ′hψ
(−1)(t) +Z ′iζ},(2.7)
where γs is the L-length vector of parameters linking the L-length vector
of the slopes of the trajectories at time t, ψ′(t) to the hazard at time t and
γh is the L-length vector of parameters linking the L-length vector of the
cumulative histories of the trajectories up to time t, ψ−1(t) to the hazard
at time t.
As in the case where only the trajectory value at time t is linked to the
hazard at time t, the cumulative hazard can be written as
ez
′
i
ζ
J∑
j=1
Hij(β, γ, γs, γh, λ),
where
Hij(β, γ, γs, γh, λ)
= I{si ≥ uj−1}λj(2.8)
×
∫ min(uj ,si)
uj−1
exp{γ′ψ(u) + γ′sψ
′(u) + γ′hψ
(−1)(u)}du
and γs = (γs1, . . . , γsL)
′ and γh = (γh1, . . . , γhL)
′. Because equation (2.8) does
not have a closed form solution, we evaluate it numerically using Gaussian
quadrature.
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The distribution for an individual’s time to event, si, given the trajectory
function and choice of hazard regression, is given by
f(si, νi|Yi) = λ(si)
νi exp{νi(γ
′ψ(si) + γ
′
sψ
′(si) + γ
′
hψ
(−1)(si) + z
′
iζ)}
(2.9)
× exp
{
−ez
′
i
ζ
J∑
j=1
Hij(β, γ, γs, γh, λ)
}
,
where νi is the censoring indicator for subject i.
3. Estimation. We can now express the ith subject’s contribution to the
joint likelihood function as
f(Yi, si, νi) = f(si, νi|Yi)× f(Yi),
f(Yi, si, νi)∝ λ(si)
νi exp{νi(γ
′ψ(si) + γ
′
sψ
′(si) + γ
′
hψ
(−1)(si) + z
′
iζ)}
× exp
{
−ez
′
i
ζ
J∑
j=1
Hij(β, γ, γs, γh, λ)
}
×
1
|Σ|mi
exp
{
−
1
2
mi∑
j=1
(Yij − ψ(tij))
′Σ−1(Yij −ψ(tij))
}
.
We then specify the prior distributions for the parameters in the likelihood
as follows. We assume (γ, γs, γh)
′ ∼ N3L(G0,G1), Σ ∼WishartνΣ(S
−1
Σ ) and
λj ∼ gamma(d0j , d1j). We may also specify priors on the hyperparameters of
β, αl ∼Np(C0l,C1l), b0l ∼Np(A0l,A1l) and V
−1
0l ∼Wishartνv0l (S
−1
v0l
). Here,
Wishartν(S
−1) denotes the Wishart distribution with ν degrees of freedom
and scale matrix S−1 and gamma(a, b) denotes the gamma distribution with
shape parameter a and scale parameter b. The prior distributions were cho-
sen to be as general as possible while still being proper and conjugate to the
likelihood when possible.
We use the Gibbs sampler [Gelfand and Smith (1990)] to sample from
the posterior distribution of the parameters. Because the full condition-
als of γ, γs, γh and ζ are log-concave, we use adaptive rejection sampling
(ARS) [Gilks and Wild (1992)] to sample from them. We use the slice sam-
pler [Neal (2003)] to sample the random effects, βij , j = 1, . . . , q, i= 1, . . . ,N .
The full conditionals of λ, Σ, V and b are sampled from directly. The esti-
mation procedure is implemented in R [R Development Core Team (2006)]
and C with code available from the author.
4. Model comparison. We examine two statistics for model comparison,
the deviance information criterion (DIC) [Spiegelhalter et al. (2002)] and the
conditional predictive ordinate (CPO) [Gelfand, Dey and Chang (1992)].
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The DIC is a measure of the deviance penalized for the number of pa-
rameters in the model which may be difficult to ascertain in hierarchical
models and is therefore estimated. The DIC is the sum of the deviance es-
timated using the posterior estimates of the parameters, D(Θ¯), and twice
the effective number of parameters, pD. The effective number of parameters
is estimated by pD =D(Θ)−D(Θ¯), where D(Θ) is the posterior mean of
the deviance (the average of the deviances calculated using the estimated
parameters at each step of the MCMC sampler). For the model presented
in this paper, the DIC can be expressed as
DIC = 2
1
G
G∑
g=1
N∑
i=1
log{f(si, νi, Yi|Θ
(g))} −
N∑
i=1
log{f(si, νi, Yi|Θ¯)},
where Θ(g) denotes the parameter samples at the gth, g = 1, . . . ,G, iteration
of the Gibbs sampler and Θ¯ represents the means of the posterior samples.
A smaller DIC indicates a better fit when comparing models.
For the ith observation, the CPO statistic is defined as
CPO i = f(si, νi, Yi|D
(−i)) =
∫
f(si, νi, Yi|Θ,Di)pi(Θ|D
(−i))dΘ,(4.1)
where Θ denotes the model parameters, Di denotes the ith patient’s covari-
ate data and D(−i) denotes the covariate data for all the patients except
the ith patient. We cannot obtain a closed form solution for (4.1); however,
Chen, Shao and Ibrahim [(2000), Chapter 10] show that a Monte Carlo
approximation of (4.1) is
ĈPO i =
(
1
G
G∑
g=1
1
f(si, νi, Yi|Θ(g))
)
−1
,
where Θ(g) denotes the parameter samples at the gth, g = 1, . . . ,G, itera-
tion of the Gibbs sampler. A large CPO value indicates a better fit. We
can compare different models using the sums of the logs of the CPOs of the
individual observations, also known as the log pseudo-marginal likelihood
(LPML). Models with greater LPML =
∑
log(ĈPO i) values will indicate a
better fit. Both the DIC and LPML are designed to measure a model’s pre-
dictive ability, although the DIC is based on a penalized deviance approach
and the LPML is based on a cross-validated approach.
5. Application. HIVNET 012, conducted in Uganda, was a double-blinded
controlled randomized trial of single dose nevirapine for the mother and new-
born infant versus AZT administered only to the mother to prevent mother
to child transmission (MTCT) of HIV. In spite of the success of nevaripine
in reducing the risk of transmission, many infants still experienced MTCT
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of HIV. To better understand HIV infection in young children, 128 of those
infants were enrolled in a long term follow-up study and followed until age 5
or death. CD4 cell percent and HIV viral load are known indicators of dis-
ease progression. TLC is also being studied for its potential use in resource-
poor settings where routine CD4 and viral load monitoring may be cost
prohibitive. In this section we examine the association between longitudinal
measures of CD4 cell percent, viral load and TLC and time until death using
separate models (one biomarker per model) in the HIVNET 012 long term
follow-up study using the methods proposed in the previous sections.
Seventy infants died during follow-up. Jump points for the baseline hazard
function were selected based on quantiles of the event times so that approxi-
mately 8 events occurred between the jump points. Infants had between one
and thirteen longitudinal measures with a median of four. Overall, there
were a total of 594 measurements of CD4 percent, 603 measurements of vi-
ral load and 763 measurements of TLC. 13% of the CD4 percent measures,
7% of the viral load measures and 16% of the TLC measures are taken at
time 0. In this analysis we placed the knots for the splines based on the
quantiles of the data; therefore, this clumping of measurement times limits
the number of knots we could select before we start placing multiple knots
at 0, making the slope undefined. Therefore, for CD4 percent, we fit models
with q = 5, . . . ,10. For TLC, we fit models with q = 5, . . . ,9. For compari-
son to potential models with more basis functions, we also fit models with
equally spaced knots with q = 11 for CD4 percent and q = 10 for TLC. For
viral load, we can fit models with q = 5, . . . ,19. Additionally, we included
age at first positive HIV test as a covariate in the hazard model; therefore,
the interpretation of ζ is the change in the log hazard associated with a 1
month increase in the age of the infant at the time of the first positive HIV
test. We implemented the Gaussian quadrature procedure using 10 points.
We also ran models with higher q using 50 points and found no difference
in the estimates.
Table 1 shows the estimated values of the parameters of interest along with
their 95% credible intervals obtained from fitting the data to three versions
of the hazard model shown in equation (2.7), one with γs = 0 and γh = 0,
one with γh = 0 and one with γs = 0, for a range of q. The Gibbs sampler
was run twice with different starting values and seeds for the random num-
ber generator for 100,000 iterations for each model with a burn-in of 10,000.
Samples from every 10th iteration were saved to reduce possible autocorre-
lation. The resulting sample was used to compute parameter estimates and
credible intervals as well as DIC and LPML. Based on DIC, the minimum
number of basis functions for a cubic B-spline, q = 5, is not adequate for
any of the three longitudinal outcomes. Although not shown, models with
equally spaced knots never outperformed the models with knots based on
quantiles according to DIC or LPML. There were no meaningful differences
1
0
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Table 1
Results from the models for the three markers of HIV disease progression
γ γs γh (×100) ζ DIC LPML
VL
q = 5 current 1.34 (0.87,1.89) −0.08 (−0.17,−0.01) 1644 −744
+slope 1.57 (1.06,2.18) 5.23 (1.91,8.62) −0.07 (−0.16,0.01) 1607 −726
+history 0.72 (−0.02,1.43) 5.56 (1.08,11.45) −0.09 (−0.19,−0.02) 1632 −737
q = 6 current 1.45 (0.93,2.03) −0.08 (−0.18,−0.01) 1635 −741
+slope 1.88 (1.32,2.53) 2.79 (1.48,4.31) −0.07 (−0.17,0.01) 1590 −717
+history 0.95 (0.20,1.73) 4.26 (−0.07,9.89) −0.09 (−0.20,−0.01) 1633 −736
q = 7 current 1.58 (1.06,2.21) −0.08 (−0.18,−0.01) 1649 −735
+slope 2.03 (1.49,2.70) 1.49 (0.91,2.25) −0.07 (−0.19,0.02) 1647 −709
+history 1.20 (0.47,1.99) 3.28 (−0.97,8.38) −0.09 (−0.19,−0.01) 1653 −734
q = 8 current 1.64 (1.11,2.28) −0.09 (−0.18,−0.01) 1646 −731
+slope 1.93 (1.34,2.62) 0.88 (0.29,1.6) −0.09 (−0.19,0) 1616 −715
+history 1.22 (0.47,2.04) 3.84 (−0.63,9.59) −0.09 (−0.21,−0.01) 1655 −728
q = 9 current 1.62 (1.09,2.27) −0.08 (−0.18,−0.01) 1662 −730
+slope 1.92 (1.31,2.66) 0.98 (−0.32,2.22) −0.08 (−0.19,0.00) 1633 −714
+history 1.26 (0.54,2.07) 3.27 (−1.07,8.78) −0.10 (−0.20,−0.03) 1668 −725
CD4
q = 5 current −0.83 (−1.17,−0.54) −0.12 (−0.22,−0.05) 1767 −743
+slope −0.87 (−1.22,−0.56) −1.81 (−4.24,0.37) −0.13 (−0.23,−0.05) 1764 −732
+history −0.6 (−1.03,−0.19) −2.05 (−4.75,0.36) −0.13 (−0.23,−0.05) 1747 −731
q = 6 current −0.81 (−1.15,−0.51) −0.12 (−0.22,−0.04) 1738 −741
+slope −0.91 (−1.29,−0.58) −1.47 (−3.32,0.80) −0.12 (−0.22,−0.05) 1728 −730
+history −0.57 (−1.02,−0.15) −1.76 (−4.14,0.38) −0.13 (−0.23,−0.05) 1722 −726
q = 7 current −0.96 (−1.34,−0.62) −0.12 (−0.22,−0.05) 1674 −731
+slope −0.98 (−1.39,−0.63) −0.38 (−1.36,0.82) −0.12 (−0.22,−0.05) 1672 −719
+history −0.77 (−1.29,−0.29) −1.2 (−3.74,1.03) −0.13 (−0.23,−0.05) 1666 −723
